[PDF][PDF] GA4GH: International policies and standards for data sharing across genomic research and healthcare

HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz… - Cell genomics, 2021 - cell.com
Summary The Global Alliance for Genomics and Health (GA4GH) aims to accelerate
biomedical advances by enabling the responsible sharing of clinical and genomic data …

Cardiovascular care innovation through data-driven discoveries in the electronic health record

LS Dhingra, M Shen, A Mangla, R Khera - The American Journal of …, 2023 - Elsevier
The electronic health record (EHR) represents a rich source of patient information,
increasingly being leveraged for cardiovascular research. Although its primary use remains …

An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting

S Crisafulli, Z Khan, Y Karatas, M Tuccori… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction The evaluation of the post-marketing safety profile of drugs is a continuous
monitoring process for approved and marketed medicines and it is crucial for detecting new …

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment

A Zemplényi, K Tachkov, L Balkanyi… - Frontiers in Public …, 2023 - frontiersin.org
Background Artificial intelligence (AI) has attracted much attention because of its enormous
potential in healthcare, but uptake has been slow. There are substantial barriers that …

A natural language processing algorithm to improve completeness of ecog performance status in real-world data

AB Cohen, A Rosic, K Harrison, M Richey, S Nemeth… - Applied Sciences, 2023 - mdpi.com
Featured Application Critical clinical variables, such as ECOG performance status, are
required for retrospective research but may be incomplete. A natural language processing …

Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS

K Kostka, T Duarte-Salles, A Prats-Uribe… - Clinical …, 2022 - Taylor & Francis
Purpose Routinely collected real world data (RWD) have great utility in aiding the novel
coronavirus disease (COVID-19) pandemic response. Here we present the international …

The challenges of outcomes-based contract implementation for medicines in Europe

N Bohm, S Bermingham, F Grimsey Jones… - …, 2022 - Springer
Objectives The aim was to outline the challenges of implementing outcomes-based
contracts (OBCs) in Europe. Methods A scoping review was conducted, building on the …

From inception to ConcePTION: genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding

NH Thurin, R Pajouheshnia, G Roberto… - Clinical …, 2022 - Wiley Online Library
In 2019, the Innovative Medicines Initiative (IMI) funded the ConcePTION project—Building
an ecosystem for better monitoring and communicating safety of medicines use in …

Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real-world data: opportunities and challenges

M Gomes, N Latimer, M Soares, S Dias, G Baio… - …, 2022 - Springer
Evidence about the relative effects of new treatments is typically collected in randomised
controlled trials (RCTs). In many instances, evidence from RCTs falls short of the needs of …

Using iterative pairwise external validation to contextualize prediction model performance: a use case predicting 1-year heart failure risk in patients with diabetes …

RD Williams, JM Reps, JA Kors, PB Ryan, E Steyerberg… - Drug Safety, 2022 - Springer
Introduction External validation of prediction models is increasingly being seen as a
minimum requirement for acceptance in clinical practice. However, the lack of …